BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36695064)

  • 1. [Clinical Impact Assessment and Utilization Prospects of the t(11:18) Chromosomal Translocation in Gastric MALT Lymphoma in Koreans: A Single Center Retrospective Analysis].
    Jung H; Shin DW; Cheung DY; Lee HH; Kim JI; Park SH; Kim TJ
    Korean J Gastroenterol; 2023 Jan; 81(1):29-35. PubMed ID: 36695064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.
    Dong G; Liu C; Ye H; Gong L; Zheng J; Li M; Huang X; Huang X; Huang Y; Shi Y; Yin W; Gao Z
    Int J Hematol; 2008 Dec; 88(5):516-523. PubMed ID: 18949449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
    Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
    Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
    Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
    Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Efficacy of Radiotherapy in
    Park BS; Lee SH
    Korean J Gastroenterol; 2019 Jan; 73(1):19-25. PubMed ID: 30690954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I(E1) gastric MALT lymphoma.
    Choi JY; Lee GH; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Jung HY; Kim JH
    Helicobacter; 2011 Feb; 16(1):36-41. PubMed ID: 21241410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and t(11;18)(q21;q21) translocation in gastric malt lymphoma.
    Lima KS; Albuquerque W; Arantes VN; Drummond-Lage AP; Coelho LG
    Arq Gastroenterol; 2014; 51(2):84-9. PubMed ID: 25003257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission].
    Kim SJ; Yang S; Min BH; Lee JH; Rhee PL; Rhee JC; Kim JJ
    Korean J Gastroenterol; 2010 Feb; 55(2):94-9. PubMed ID: 20168055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
    Takigawa H; Yuge R; Masaki S; Otani R; Kadota H; Naito T; Hayashi R; Urabe Y; Oka S; Tanaka S; Chayama K; Kitadai Y
    Gastric Cancer; 2021 Jul; 24(4):937-945. PubMed ID: 33638751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the
    Iwamuro M; Takenaka R; Nakagawa M; Moritou Y; Saito S; Hori S; Inaba T; Kawai Y; Toyokawa T; Tanaka T; Yoshino T; Okada H
    World J Gastroenterol; 2017 Sep; 23(33):6155-6163. PubMed ID: 28970731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
    Nakamura T; Inagaki H; Seto M; Nakamura S
    J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience.
    Ryu KD; Kim GH; Park SO; Lee KJ; Moon JY; Jeon HK; Baek DH; Lee BE; Song GA
    Gut Liver; 2014 Jul; 8(4):408-14. PubMed ID: 25071906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Helicobacter pylori eradication for gastric MALT lymphoma].
    Nakamura S; Matsumoto T; Kitazono T
    Nihon Rinsho; 2013 Aug; 71(8):1424-8. PubMed ID: 23967674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.